NPPB and hydrops fetalis: Individuals who had LVH and either cTnT or NTproBNP elevation were at a 4-fold higher risk of HF or CV death after multivariable adjustment for CV risk factors, renal function, and LV mass compared with those who did not have LVH and elevated biomarkers.